Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595215 · ClinicalTrials.gov registry record · NA
Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home
A NA study, sponsored by Theranova, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03595215 is a NA study that has completed, run by Theranova, L.L.C.. The registered enrollment target is 18 participants.
The verdict
NCT03595215, a NA study, has completed, sponsored by Theranova, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This pilot clinical study, which focuses on feasibility and proof-of-principle, will be conducted in 11 female subjects (55-100 years old) with UI. Subjects will use the device three times a week for 8 weeks and complete 3-day "voiding diaries" to record instances of UI episodes and OAB quality of life.
Interventions
- DEVICE TENS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-09-10 |
| Est. Completion | 2019-09-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03595215
The ClinicalTrials.gov registry entry for NCT03595215 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranova, L.L.C., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which TENS is the first listed.
NCT03595215 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03595215 about?
NCT03595215 is a clinical study titled "Posterior Tibial Nerve Stimulation's Effectiveness in UI Frequency in Overactive Patients in Home". This pilot clinical study, which focuses on feasibility and proof-of-principle, will be conducted in 11 female subjects (55-100 years old) with UI. Subjects will use the device three times a week for 8 weeks and complete 3-day "voiding diaries" to record instances of UI episodes and OAB quality of l...
What is the current status of trial NCT03595215?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-09-10. Estimated completion is 2019-09-17.
What interventions are being tested in trial NCT03595215?
The interventions under investigation include: TENS (DEVICE).
Who is sponsoring clinical trial NCT03595215?
This trial is sponsored by Theranova, L.L.C., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.